Therapeutic differentiation of tumor-derived insulin-producing cells selected for resistance to diabetogenic drugs

Experimental Diabesity Research

Volumn 1, Issue 3, 2000, Pages 233-237

  Bloch, Konstantin ^a   Vardi, Pnina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cell differentiation; Insulin; RIN cells; Secretagogues; Streptozotocin resistance

Indexed keywords

CYCLIC AMP; FORSKOLIN; GLUCOSE; INSULIN; ISOBUTYLMETHYLXANTHINE; STREPTOZOCIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; DRUG EFFECT; DRUG RESISTANCE; INSULINOMA; KINETICS; METABOLISM; PANCREAS ISLET; PANCREAS TUMOR; PHYSIOLOGY; RAT; SECRETION;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; DRUG RESISTANCE; FORSKOLIN; GLUCOSE; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; KINETICS; PANCREATIC NEOPLASMS; RATS; STREPTOZOCIN; TUMOR CELLS, CULTURED;

EID: 0034577881     PISSN: 15438600     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/edr.2000.233     Document Type: Review

References (10)

1. Newgard, C. B. (1994). Cellular engineering and gene therapy strategies for insulin replacement in diabetes, Diabetes, 43, 341-350.
2. Efrat, S. (1998). Cell-based therapy for insulin-dependent diabetes mellitus, Eur. J. Endocrinol., 138, 129-133.
3. Waxman, S., Borden, E. C., Lotan, R., Levens, D. and Young, C. W. (1993). Differentiation therapy of cancer: laboratory and clinical investigations, Cancer Res., 53, 4109-4115.
4. Jetten, A. M., Nervi, C. and Vollberg, T. M. (1992). Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr., 13, 93-100.
5. Prados, J., Melguizo, C., Marchai, J. A., Velez, C., Alvarez, L. and Aranega, A. (1998). Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D. Int. J. Cancer, 75, 379-383.
6. Marchal, J. A., Prados, J., Melguizo, C., Gomes, J. A., Campos, J., Gallo, M. A., Espinosa, A., Arena, N. and Aragenda, A. (1999). GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells. Br. J. Cancer, 79, 807-813.
7. Bloch, K. and Vardi, P. (1996). Streptozotocin-induced selection of insulin enriched cells in a heterogeneous population of RINm cells. Diabetologia, 39 (Suppl. 1), 72.
8. Bloch, K., Zemel, R., Bloch, O., Grief, H. and Vardi, P. (2000). Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells. International J. Experimental of Diabetes Research (in press).
9. Gazdar, A. F., Chick, W. L., Oie, H. K., Sims, H. L., King, D. L., Weir, G. C. and Lauris, V. (1980). Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor, Proc. Natl. Acad. Sci. USA, 77, 3519-3523.
10. Prados, J., Melguizo, C., Fernandez, A., Aranega, A. E., Alvarez, L. and Aranega, A. (1995). Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin D. J. Pathol., 180, 85-89.